Andrea Tedeschi

Piacenza, 29121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

The New Cardio-Oncology Frontier in Hematologic Cancers: Cardiovascular Toxicities of CAR-T Cells and Bispecific T-Cell Engagers.

The New Cardio-Oncology Frontier in Hematologic Cancers: Cardiovascular Toxicities of CAR-T Cells and Bispecific T-Cell Engagers.

Journal: Journal of clinical medicine

Published: June 30, 2026

Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management.

Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management.

Journal: Journal of clinical medicine

Published: June 24, 2026

Cardiovascular Involvement in Erdheim-Chester Disease Presenting as Pericardial Tamponade: A Case Report and Multimodality Imaging Review.

Cardiovascular Involvement in Erdheim-Chester Disease Presenting as Pericardial Tamponade: A Case Report and Multimodality Imaging Review.

Journal: Journal of clinical medicine

Published: May 04, 2026

Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

Journal: International journal of molecular sciences

Published: May 04, 2026

ANMCO-SICPED consensus document on cardio-oncological transition in childhood cancer survivors

ANMCO-SICPED consensus document on cardio-oncological transition in childhood cancer survivors

Journal: Giornale italiano di cardiologia (2006)

Published: April 29, 2026

SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

Journal: International journal of molecular sciences

Published: March 12, 2026

Cardiogenetics in Piacenza: integrated care and telemedicine for precision medicine

Cardiogenetics in Piacenza: integrated care and telemedicine for precision medicine

Journal: Giornale italiano di cardiologia (2006)

Published: February 25, 2026

Arrhythmias in patients with cancer: Pathophysiology, risk stratification and clinical implications.

Arrhythmias in patients with cancer: Pathophysiology, risk stratification and clinical implications.

Journal: Trends in cardiovascular medicine

Published: February 12, 2026

Cardiopulmonary Exercise Testing and HFpEF: Diagnostic and Therapeutic Perspectives.

Cardiopulmonary Exercise Testing and HFpEF: Diagnostic and Therapeutic Perspectives.

Journal: Healthcare (Basel, Switzerland)

Published: October 13, 2025

Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology

Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology

Journal: Giornale italiano di cardiologia (2006)

Published: October 02, 2025

Advancing Heart Failure Care: Breakthroughs and Emerging Strategies.

Advancing Heart Failure Care: Breakthroughs and Emerging Strategies.

Journal: Journal of clinical medicine

Published: September 04, 2025

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Journal: International journal of molecular sciences

Published: August 23, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026